Recent Patents on Anti-Cancer Drug Discovery
Title:Acknowledgements to Contributors
Volume: 14 Issue: 4
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Acknowledgements to Contributors, Recent Patents on Anti-Cancer Drug Discovery 2019; 14 (4) . https://dx.doi.org/10.2174/157489281404191220161218
DOI https://dx.doi.org/10.2174/157489281404191220161218 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
8
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
IGF-1 Gene Therapy as a Potentially Useful Therapy for Spontaneous Prolactinomas in Senile Rats
Current Gene Therapy Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma
Current Molecular Medicine The Anti-Cancer Charm of Flavonoids: A Cup-of-Tea Will Do!
Recent Patents on Anti-Cancer Drug Discovery Patent Selections
Recent Patents on Anti-Infective Drug Discovery Extracellular Signals for Guiding Mesenchymal Stem Cells Osteogenic Fate
Current Stem Cell Research & Therapy Effect of Non-Ionizing Electromagnetic Fields of Anthropic Origin on Male Fertility
Current Chemical Biology Advances in Sickle Cell Disease Treatment: from Drug Discovery Until the Patient Monitoring
Cardiovascular & Hematological Agents in Medicinal Chemistry Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
Current Medicinal Chemistry Hydroxylated Dendrimer-Stabilized Gold and Silver Nanoparticles: Spontaneous Formation, Characterization, and Surface Properties
Current Nanoscience Targeting EZH2 for Cancer Therapy: Progress and Perspective
Current Protein & Peptide Science Pericyclic Reactions for Antivirals: Synthesis of 4-Bromo-N-[(1R*,4S*)-4- hydroxy-2-cyclohexen-1-yl]-2-thiazolecarboxamide
Letters in Organic Chemistry Emerging Technologies for Cancer Research: Towards Personalized Medicine with Microfluidic Platforms and 3D Tumor Models
Current Medicinal Chemistry A synopsis on the linkage between age-related dementias and vascular disorders
CNS & Neurological Disorders - Drug Targets Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Radiolabelled Probes Targeting Tumor Hypoxia for Personalized Medicine
Current Pharmaceutical Design GABAA Receptor Channel Pharmacology
Current Pharmaceutical Design Application of Supercritical Fluid in Nanolithographic Processes
Recent Patents on Nanotechnology Small Non-Coding RNAs as Novel Therapeutics
Current Molecular Medicine Tumor Protein p63/microRNA Network in Epithelial Cancer Cells
Current Genomics